• 1
    Wei JT, Calhoun E, Jacobsen SJ. Urologic diseases in America project: benign prostatic hyperplasia. J Urol 2005; 173: 12561261
  • 2
    Wade B. Etiology, epidemiology, and natural history. Urol Clin North Am 2009; 36: 403415
  • 3
    McConnell JD, Roehrborn CG, Bautista OM et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 2003; 349: 23872398
  • 4
    Meigs JB, Mohr B, Barry MJ, Collins MM, McKinlay JB. Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men. J Clin Epidemiol 2001; 54: 935944
  • 5
    Giovannucci E, Rimm EB, Chute C et al. Obesity and benign prostatic hyperplasia. Am J Epidemiol 1994; 140: 9891002
  • 6
    Rohrmann S, Crespo CJ, Weber JR, Smit E, Giovannucci E, Platz EA. Association of cigarette smoking, alcohol consumption and physical activity with lower urinary tract symptoms in older American men: findings from the third National Health And Nutrition Examination Survey. BJU Int 2005; 96: 7782
  • 7
    Platz EA, Kawachi I, Rimm EB et al. Physical activity and benign prostatic hyperplasia. Arch Intern Med 1998; 158: 23492356
  • 8
    Fowke JH, Motley S, Smith JA Jr et al. Association of nonsteroidal anti-inflammatory drugs, prostate specific antigen and prostate volume. J Urol 2009; 181: 20642070
  • 9
    Barry MJ, Fowler FJ Jr, O'Leary MP et al. The american urological association symptom index for benign prostatic hyperplasia. The measurement committee of the american urological association. J Urol 1992; 148: 15491557
  • 10
    Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982; 36: 936942
  • 11
    Ainsworth BE, Haskell WL, Whitt MC et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000; 28: S498504
  • 12
    Voorrips LE, Ravelli AC, Dongelmans PC, Deurenberg P, VanStraveren WA. A physical activity questionnaire for the elderly. Med Sci Sports Exerc 1991; 23: 974979
  • 13
    Parsons JK, Kashefi C. Physical activity, benign prostatic hyperplasia, and lower urinary tract symptoms. Eur Urol 2008; 53: 12281235
  • 14
    Fowke JH, Motley SS, Cookson MS et al. The association between body size, prostate volume and prostate-specific antigen. Prostate Cancer Prostatic Dis 2006; 10: 137142
  • 15
    Kristal AR, Arnold KB, Schenk JM et al. Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. J Urol 2007; 177: 13951400
  • 16
    Bray GA. The underlying basis for obesity: relationship to cancer. J Nutr 2002; 132: 3451S3455
  • 17
    Furukawa S, Fujita T, Shimabukuro M et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114: 17521761
  • 18
    Dahle SE, Chokkalingam AP, Gao YT, Deng J, Stanczyk FZ, Hsing AW. Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia. J Urol 2002; 168: 599604
  • 19
    Nandeesha H, Koner BC, Dorairajan LN, Sen SK. Hyperinsulinemia and dyslipidemia in non-diabetic benign prostatic hyperplasia. Clin Chim Acta 2006; 370: 8993
  • 20
    Parsons JK, Carter HB, Partin AW et al. Metabolic factors associated with benign prostatic hyperplasia. J Clin Endocrinol Metab 2006; 91: 25622568
  • 21
    Hammarsten J, Hogstedt B, Holthuis N, Mellstrom D. Components of the metabolic syndrome – risk factors for the development of benign prostatic hyperplasia. Prostate Cancer Prostatic Dis 1998; 1: 157162
  • 22
    Hammarsten J, Hogstedt B. Clinical, haemodynamic, anthropometric, metabolic and insulin profile of men with high-stage and high-grade clinical prostate cancer. Blood Press 2004; 13: 4755
  • 23
    Rohrmann S, Smit E, Giovannucci E, Platz EA. Association between markers of the metabolic syndrome and lower urinary tract symptoms in the Third National Health and Nutrition Examination Survey (NHANES III). Int J Obes (Lond) 2005; 29: 310316
  • 24
    Hammarsten J, Hogstedt B. Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia. Eur Urol 2001; 39: 151158
  • 25
    Mueller PJ. Physical (in)activity-dependent alterations at the rostral ventrolateral medulla: influence on sympathetic nervous system regulation. Am J Physiol Regul Integr Comp Physiol 2010; 298: R14681474
  • 26
    Azadzoi KM, Yalla SV, Siroky MB. Human bladder smooth muscle cell damage in disturbed oxygen tension. Urology 2011; 78: 96715
  • 27
    Fowke JH, Munro H, Signorello LB, Blot WJ, Penson DF. Association between socioeconomic status (SES) and lower urinary tract symptom (LUTS) severity among black and white men. J Gen Intern Med 2011; 26: 13051310